drugset / Trial / NCT05365880

Sphenopalatine Ganglion Block for the Treatment of Post-Stroke Headache

NCT05365880 ↗

Phase 2 Withdrawn University of Utah
RandomizedParallel-groupSingle-blindTreatment

Summary

Determine the effects of sphenopalatine ganglion (SPG) block in post-stroke headache.

Timeline

Start
2022-03-23
Primary completion
2025-03-22
Completion
2025-06-01

Outcome

Outcome not reported

Stopped (Enrollment): “Due to COVID-19 and both co-investigators have departed from the institution, we weren't able to enroll participants. Additionally, funding has lapse”

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 2 ml Intranasal
Subject Lidocaine Other / unclassified 2 % Intranasal